Inflammatory Bowel Disease Treatment Forecast Report – Designed for Decision Makers and Product Teams
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Inflammatory Bowel Disease Treatment Market?
The market size of treatments for inflammatory bowel disease has witnessed robust growth in the past years. The value is set to increase from $25.26 billion in 2024 to $27.45 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%. The growth observed during the historical period is due to factors such as a higher number of inflammatory bowel disease cases, a growing demand for biologics and immunomodulators, the development of improved treatment methods, an increase in the elderly population, and heightened public awareness about the disease.
What Growth Rate Is Forecasted for the Inflammatory Bowel Disease Treatment Market by 2029?
Predictions suggest the market size for the treatment of inflammatory bowel disease will observe a meteoric rise in the coming years. It’s forecasted that by 2029, it will climb to $40.27 billion, expanding at a compound annual growth rate (CAGR) of 10.1%. The growth throughout the projected period can be traced back to an upsurge in research and development activities, swelling demand for biosimilars, a higher frequency of inflammatory bowel disease in developing markets, a surge in personalized medicine demand, and the incorporation of precision medicine in IBD therapies. Noteworthy trends predicted during the forecast period consist of an increase in product introductions and approvals, personalized dosage and treatment regimens in IBD management, application of telemedicine for distantly monitoring IBD patients, investigation into microbiome-focused therapies for IBD, and the embracing of value-focused care models in IBD treatment.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6704&type=smp
Which Key Companies Are Shaping the Future of the Inflammatory Bowel Disease Treatment Market?
Major companies operating in the inflammatory bowel disease treatment market include AbbVie Inc., Biogen Inc., Johnson & Johnson, Amgen Inc., Advanced Gastroenterology and Surgery Associates P. A., Atlanta Gastroenterology Associates LLC, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cedars-Sinai Medical Center, Celgene Corporation, Cleveland Clinic Foundation, Digestive Disease Associates of Rockland P. C., Eli Lilly and Company, Gastrointestinal Specialists Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Illinois Gastroenterology Group LLC, The Johns Hopkins Hospital Inc., Massachusetts General Hospital, Mayo Clinic, Merck & Co. Inc., Mount Sinai Health System Inc., Novartis International AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Texas Digestive Disease Consultants P. A., The Oregon Clinic – Gastroenterology West P. C., Salix Pharmaceuticals Inc., Vifor Pharma AG, Zydus Pharmaceuticals (USA) Inc.
Which Factors Are Driving Demand in the Inflammatory Bowel Disease Treatment Industry?
The escalating incidence of Crohn’s disease and ulcerative colitis is a significant factor propelling the inflammatory bowel disease treatment market. Crohn’s disease and ulcerative colitis are variants of inflammatory bowel diseases (IBD) which lead to inflammation and ulcers (sores) in the digestive tract. The growing instances of Crohn’s disease and ulcerative colitis are set to augment demand for inflammatory bowel disease treatments, known for their efficacy in reducing bowel inflammation and managing or staving off medical complications. For example, a research study published in the United States National Library of Medicine in March 2022 noted that approximately 1.6 million Americans are currently living with inflammatory bowel disease (either Crohn’s disease or ulcerative colitis). Furthermore, approximately 70,000 new IBD diagnoses are made annually in the USA. Consequently, the increasing incidence of Crohn’s disease and ulcerative colitis is likely to fuel the expansion of the inflammatory bowel disease treatment market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=6704&type=smp
How Is the Inflammatory Bowel Disease Treatment Market Segmented by Several Divisions?
The inflammatory bowel disease treatment market covered in this report is segmented –
1) By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes
2) By Type: Crohn’s Disease, Ulcerative Colitis
3) By Route Of Administration: Oral, Injectable
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Aminosalicylates: Mesalamine, Sulfasalazine, Balsalazide
2) By Corticosteroids: Prednisone, Budesonide, Hydrocortisone
3) By TNF Inhibitors: Infliximab, Adalimumab, Certolizumab pegol
4) By IL Inhibitors: Ustekinumab, Guselkumab
5) By Anti-Integrin: Vedolizumab, Natalizumab
6) By JAK Inhibitors: Tofacitinib, Filgotinib
7) By Other Drug Classes: Antibiotics, Immunosuppressants, Other Novel Therapies
What are the Emerging Market Trends Driving the Growth of the Inflammatory Bowel Disease Treatment Industry?
Technological progression is a prominent trend that is increasingly popular in the inflammatory bowel disease treatment sector. Significant companies in the market are emphasizing the utilization of AI-driven registries to gain a competitive advantage. For example, Verantos, a company based in California that specializes in real-world evidence (RWE), introduced the Inflammatory Bowel Disease Pragmatic Registry in May 2024. This leverages advanced artificial intelligence to produce reliable, real-world evidence for ulcerative colitis and Crohn’s disease. The goal of the registry is to aid in the creation of effective therapies by offering a comprehensive dataset with over 3 billion data points related to patient care. This enables biopharmaceutical researchers to gain detailed understanding of disease severity, medication efficacy, and clinical results by using both structured and unstructured data collected from electronic health records.
Access The Full Report Here:
Which Regions Are Driving Growth in the Inflammatory Bowel Disease Treatment Market?
North America was the largest region in the inflammatory bowel disease treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inflammatory bowel disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6704
This Report Delivers Insight On:
1. How big is the inflammatory bowel disease treatment market, and how is it changing globally?
2. Who are the major companies in the inflammatory bowel disease treatment market, and how are they performing?
3. What are the key opportunities and risks in the inflammatory bowel disease treatment market right now?
4. Which products or customer segments are growing the most in the inflammatory bowel disease treatment market?
5. What factors are helping or slowing down the growth of the inflammatory bowel disease treatment market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
